Contact CRAFT Therapeutics
For partnership, investor, and talent inquiries, please use the form below or reach out to the appropriate team.
How Partners Work With ALX
Partners evaluate ALX feasibility, license ALX variants, and obtain ALX manufacturing rights for successor drug programs. ALX enables structurally distinct small-molecule NCEs with improved PK, exposure, and tolerability — accelerating 505(b)(2) development and protecting franchises before LOE closes.
Contact Form
We typically respond within 2–3 business days. All submissions are reviewed by the BD team.
ALX Licensing & Manufacturing
CRAFT engages with pharma partners, CROs, CDMOs, and API manufacturers across ALX feasibility, ALX licensing, and ALX manufacturing rights.
Investors
CRAFT welcomes conversations with investors aligned with platform therapeutics, small-molecule innovation, and next-generation drug-modulation technologies.
Careers at CRAFT
CRAFT is building a small, high-caliber team across chemistry, platform engineering, and BD strategy. If you are interested in joining CRAFT, please reach out.
Location
CRAFT Therapeutics LLC
Fremont, California